Mater Misericordiae University Hospital
Mater Misericordiae University Hospital
Dublin, Ireland15 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration | Geographic Atrophy, age-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Not applicable | 2026-09-29 | NCT04796545 | |
| Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 3 | 2026-07-29 | NCT06274801 | |
| SIRONA 2 Trial Heart Failure NYHA Class III | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2026-07-27 | NCT04012944 | |
| PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds | Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Surgical Wound, Surgical Wound Infection, Wound Infection, injury | Active, not recruiting | Not applicable | 2026-07-21 | NCT05977816 | |
| Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism | Embolism, Embolism and Thrombosis, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder | Active, not recruiting | Phase 4 | 2026-07-01 | NCT04790370 | |
| PALbociclib CoLlaborative Adjuvant Study | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-06-15 | NCT02513394 | |
| ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable) | metastatic prostate carcinoma | Recruiting | Phase 3 | 2026-04-28 | NCT04916613 | |
| Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 3 | 2026-03-18 | NCT06726265 | |
| Statins for Venous Event Reduction in Patients With Venous Thromboembolism | Embolism and Thrombosis, Postthrombotic Syndrome, Thromboembolism, Venous Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder, venous insufficiency, venous thromboembolism | Recruiting | Phase 3 | 2026-01-15 | NCT04319627 | |
| Real World Data Collection on the Synergy Disc | central nervous system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, radiculopathy, spinal cord disorder | Recruiting | Not stated | 2026-01-09 | NCT06383949 | |
| TAILORx Tissue Bank | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not stated | 2025-12-19 | NCT02050750 | |
| Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2025-07-08 | NCT05123131 | |
| Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, cancer, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, rectal disorder, skin disorder | Active, not recruiting | Phase 3 | 2025-06-10 | NCT02804815 | |
| AUGUR-AI - Indocyanine Green Fluorescence Angiography Representer | Anastomotic Leak, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications | Not yet recruiting | Not stated | 2024-11-27 | NCT06708819 | |
| A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2024-11-12 | NCT01957436 |